基本信息
浏览量:16
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
She has also been involved in the setup of a new analytical HPLC method for the determination of biochemical markers of Inborn Errors of Metabolism (IEM) and she was in charge of the genetic analysis of related mutations.
In 2008, she joined the Division of Clinical Neurosciences at the University of Southampton where she was involved in the development of an in vitro model of acute neurodegenerative diseases. This model is now recognised as some of the most applicable alternatives to the use of in vivo experiments.
In 2012, dr Di Pietro joined the Institute of Inflammation and Ageing at the University of Birmingham where she is studying MicroRNAs as biomarkers in serum, urine and saliva of TBI patients and the potential role of MicroRNA-based therapy for trauma.
In 2017, Valentina Di Pietro was awarded the prestigious BRIDGE fellowship to undertake TBI research in collaboration with the University of Urbana-Champaign Illinois, USA. The fellowship allows dr Di Pietro to combine neuroimaging techniques available in the US with the results of microRNA study.
Dr Di Pietro also became board member and Chief Scientific Officer of a new company called Marker Diagnostics, interested in the development and commercialisation of the first salivary test to identify concussion using microRNAs.
In 2008, she joined the Division of Clinical Neurosciences at the University of Southampton where she was involved in the development of an in vitro model of acute neurodegenerative diseases. This model is now recognised as some of the most applicable alternatives to the use of in vivo experiments.
In 2012, dr Di Pietro joined the Institute of Inflammation and Ageing at the University of Birmingham where she is studying MicroRNAs as biomarkers in serum, urine and saliva of TBI patients and the potential role of MicroRNA-based therapy for trauma.
In 2017, Valentina Di Pietro was awarded the prestigious BRIDGE fellowship to undertake TBI research in collaboration with the University of Urbana-Champaign Illinois, USA. The fellowship allows dr Di Pietro to combine neuroimaging techniques available in the US with the results of microRNA study.
Dr Di Pietro also became board member and Chief Scientific Officer of a new company called Marker Diagnostics, interested in the development and commercialisation of the first salivary test to identify concussion using microRNAs.
研究兴趣
论文共 89 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Renata Mangione,Cesarina Giallongo,Andrea Duminuco,Enrico La Spina,Lucia Longhitano,Sebastiano Giallongo,Daniele Tibullo,Giuseppe Lazzarino,Miriam Wissam Saab, Arianna Sbriglione,Giuseppe A. Palumbo, Andrea Graziani,
Antioxidantsno. 4 (2024)
Renata Mangione,Cesarina Giallongo,Andrea Duminuco,Enrico La Spina,Lucia Longhitano,Sebastiano Giallongo,Daniele Tibullo,Giuseppe Lazzarino,Miriam Wissam Saab, Arianna Sbriglione,Giuseppe A Palumbo, Andrea Graziani,
ANTIOXIDANTSno. 5 (2023): 985-985
International journal of molecular sciencesno. 13 (2023): 10707-10707
Frontiers in neuroscience (2023): 1228927
Antioxidants (Basel, Switzerland)no. 5 (2023)
Michael Turner, Cliff Beirne,Antonio Belli,Kaj Blennow,Henrik Zetterberg, Bonnie Kate Dewar,Valentina di Pietro,Conor Gissane,Amanda Heslegrave,Etienne Laverse, Victoria McEneaney,Adrian McGoldrick,
medrxiv(2022)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn